Search research articles
Contact Us
Filters
Showing results (801-810 of 1,358) with videos related to
Page
of 136
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity
E Buchdunger, H Mett, U Trinks, et al.
Nuclear Medicine and Biology
|
May 18, 2012
[18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases
Máté D Döbrössy, Friederike Braun, Stefanie Klein, et al.
Journal of Neurochemistry
|
August 3, 2002
Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis
C Münch, M Ebstein, U Seefried, et al.
The Journal of the American Osteopathic Association
|
December 16, 1997
The anatomy of an OPTI: Part 2. The CORE system. Ohio Osteopathic Hospital Association. Ohio Association of Osteopathic Medical Directors. Ohio Osteopathic Association
C T Meyer, R Portanova, C Riley, et al.
Journal of Medicinal Chemistry
|
November 14, 1997
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines
P Traxler, G Bold, J Frei, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 6, 2008
Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice
T Meyer, L Robles-Carrillo, T Robson, et al.
Brain and Language
|
November 5, 2013
Neural correlates of cognitive dysfunction in Lewy body diseases and tauopathies: combined assessment with FDG-PET and the CERAD test battery
Sabine Hellwig, Lars Frings, Tobias Bormann, et al.
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]
|
September 30, 2022
A Novel Mixed-Method Approach to Identify Needs and Requirements for Upper Limb Assistive Technology for Persons after Stroke
Natalie Tanczak, Raffaele Ranzani, Jan T Meyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 2, 2025
[<sup>18</sup>F]FDG-PET reveals early postoperative cortical dysfunction after subthalamic nucleus deep brain stimulation in Parkinson's disease
Christian Volz, Volker A Coenen, Lars Frings, et al.
Neuroimage
|
July 4, 2008
Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach
Philipp T Meyer, Bernhard Sattler, Oliver H Winz, et al.
Page
of 136
Search research articles
Search
Showing results (801-810 of 1,358) with videos related to
Sort By:
Page
of 136
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity
E Buchdunger, H Mett, U Trinks, et al.
Nuclear Medicine and Biology
|
May 18, 2012
[18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases
Máté D Döbrössy, Friederike Braun, Stefanie Klein, et al.
Journal of Neurochemistry
|
August 3, 2002
Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis
C Münch, M Ebstein, U Seefried, et al.
The Journal of the American Osteopathic Association
|
December 16, 1997
The anatomy of an OPTI: Part 2. The CORE system. Ohio Osteopathic Hospital Association. Ohio Association of Osteopathic Medical Directors. Ohio Osteopathic Association
C T Meyer, R Portanova, C Riley, et al.
Journal of Medicinal Chemistry
|
November 14, 1997
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines
P Traxler, G Bold, J Frei, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 6, 2008
Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice
T Meyer, L Robles-Carrillo, T Robson, et al.
Brain and Language
|
November 5, 2013
Neural correlates of cognitive dysfunction in Lewy body diseases and tauopathies: combined assessment with FDG-PET and the CERAD test battery
Sabine Hellwig, Lars Frings, Tobias Bormann, et al.
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]
|
September 30, 2022
A Novel Mixed-Method Approach to Identify Needs and Requirements for Upper Limb Assistive Technology for Persons after Stroke
Natalie Tanczak, Raffaele Ranzani, Jan T Meyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 2, 2025
[<sup>18</sup>F]FDG-PET reveals early postoperative cortical dysfunction after subthalamic nucleus deep brain stimulation in Parkinson's disease
Christian Volz, Volker A Coenen, Lars Frings, et al.
Neuroimage
|
July 4, 2008
Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach
Philipp T Meyer, Bernhard Sattler, Oliver H Winz, et al.
Page
of 136